 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
Allegro Completes Enrollment for Validation Trial for BronchoGen Lung Cancer Risk Test, Anticipates Release in 2013
August 01, 2012
Allegro Completes Enrollment for Validation Trial for BronchoGen Lung Cancer Risk Test, Anticipates Release in 2013
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Allegro Raises $4.5M to Support Commercialization of Lung Cancer Test
July 7, 2011 / GenomeWeb Daily News - Allegro Licenses Lung Cancer Testing IP from Boston University, University of Utah Foundation
June 29, 2011 / GenomeWeb Daily News - GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Cynvenio to Offer Clinical PCR Testing of Isolated Circulating Tumor Cells for Select Targets
April 11, 2013 / PCR Insider - MDx/CDx Focus: New Studies on Veracyte's Afirma, Allegro's BronchoGen; MyRA App Globally Launched
March 13, 2013 / Pharmacogenomics Reporter